Advance Search

Prevalence and factors associated with osteoporosis in patients with type 2 diabetes mellitus

Dashty Al-Bustany
Department of Medicine, College of Medicine, Hawler Medical University, Erbil, Iraq.
Keywords:
Copyright and Licensing:

Copyright (c) 2025 Dashty Al-Bustany (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Share:
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Background and objective: Diabetes mellitus is a long-lasting metabolic condition with significant morbidity and mortality. This study aimed to determine the prevalence of osteoporosis in type 2 diabetes mellitus patients using a Dual-energy x-ray absorptiometry (DEXA) scan and to find out the factors that are associated with osteoporosis.

Methods: A cross-sectional study was done on 100 type 2 diabetic patients attending the medical ward of Rizgary Teaching Hospital and outpatients of internal medicine and rheumatology in Erbil City from October 2017 to March 2018.

Results: Out of a hundred patients with type 2 Diabetes Mellitus, 28 were men and 72 were women. The prevalence of osteoporosis in type 2 diabetes mellitus was 40%. The age range was from 33-91 years (The mean age 59.5 years). Out of all collected patients, 44 were current smokers. In relation to anti-diabetic medications, among a total of 100 patients, only four of them relied on diet control alone. The majorities, 69 patients, were taking oral hypoglycemic drugs, six patients were exclusively on insulin therapy, whereas 21 diabetic patients were managing their condition through a combination of oral hypoglycemic drugs and insulin therapy. The minimum duration of Diabetes among patients was 2 years. The minimum range of serum vitamin D was six ng/ml while the maximum was 35 ng/ml (mean is 21.1). The minimum serum calcium was 7 mg/dl while the maximum number was 10.6 mg/dl (the mean is 9).

Conclusion: The prevalence of osteoporosis among diabetic patients was common. Significant association was found with old age, long duration of the disease, post-menopausal status of the female and low serum vitamin D level.

PDF
PDF

Metrics

Metrics Loading ...

References

  1. Motlagh B, O’Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009; 16(3):268–80. Doi:10.1097/HJR.0b013e328322ca1b.
  2. Al Zenki S, Al Omirah H, Al Hooti S, Al Hamad N, Jackson RT, Rao A, et al. High prevalence of metabolic syndrome among Kuwaiti adults–a wake-up call for public health intervention. Int J Environ Res Public Health. 2012; 9(5):1984–96. doi:10.3390/ijerph9051984.
  3. Sherwin R, Jastreboff AM. Year in diabetes 2012: the diabetes tsunami. J Clin Endocrinol Metab. 2012; 97:4293–301. doi: 10.1210/jc.2012-3484
  4. Zella JB, DeLuca HF. Vitamin D and autoimmune diabetes. J Cell Biochem. 2003; 88:216-22. doi:10.1002/jcb.10347.
  5. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. The Lancet. 2011; 377(9773):1276–87. doi: 10.1016/s0140-6736(10)62349-5.
  6. Sozen T, Ozisik L, Başaran N. An overview and management of osteoporosis. European Journal of Rheumatology. 2017; 4(1):46–56. doi: 10.5152/eurjrheum.2016.048.
  7. Schacter GI, Leslie WD. Diabetes and osteoporosis. Endocrinology and Metabolism Clinics of North America. 2021; 50(2):275–85. doi: 10.1016/j.ecl.2021.03.005.
  8. Kanazawa A, Yamaguchi T, Yamamoto M, Yamaguchi M, Kurioka S, Yano S, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010; 94:45-49. doi: 10.1210/jc.2008-1455.
  9. Lecka-Czernik, B. Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis. Curr Osteoporos. 2010; 8:178–84. doi: 10.1007/s11914-010-0027-y
  10. LosadaE, Soldevila B, Ali M. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case–control study. Osteoporos Int. 2018; 29: 2079–86. doi: 10.1007/s00198-018-4581-y.
  11. Nihiser AJ, Lee SM, Wechsler H, McKenna MC, Odom EL, Reinold CM, et al. Body mass index measurement in schools. Journal of School Health. 2007; 77(10):651–71. doi: 10.1111/j.1746-1561.2007.00249.x
  12. Sharma B, Singh H, Chodhary P, Saran S, Mathur SK. Osteoporosis in Otherwise Healthy Patients with Type 2 Diabetes: A Prospective Gender Based Comparative Study. Indian J Endocrinol Metab. 2017; 21(4):535-9. doi: 10.4103/ijem.IJEM_108_17.
  13. RomanaM, Li-Yu JT. Investigation of the Relationship between Type 2 Diabetes and Osteoporosis Using Bayesian Inference. Journal of Clinical Densitometry. 2017; 10(4):386–90. doi: 10.1016/j.jocd.2007.08.001
  14. Si Y, Wang C, Guo Y, Xu G, Ma Y. Prevalence of Osteoporosis in Patients with Type 2 Diabetes Mellitus in the Chinese Mainland: A Systematic Review and Meta-Analysis. Iran J Public Health. 2019; 48(7):1203-14.
  15. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000; 21(2):115–37. doi: 10.1210/edrv.21.2.0395.
  16. Xu H, Wang Z, Li X, Fan M, Bao C, Yang R, et al. Osteoporosis and osteopenia among patients with type 2 diabetes aged ≥50: role of sex and clinical characteristics. Journal of Clinical Densitometry. 2020; 23(1):29-36. doi: 10.1016/j.jocd.2019.04.004
  17. Nicodemus KK, Folsom AR. Type 1 and Type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001; 24:1192–7. doi: 10.2337/diacare.24.7.1192.
  18. Goldshtein I, Nguyen AM, dePapp AE, Ish-Shalom S, Chandler JM, Chodick G, et al. Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients. Arch Osteoporosis. 2018; 13(1). doi: 10.1007/s11657-018-0432-x
  19. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes meta-analysis. Osteoporosis Int. 2017; 18:427–44. doi:10.1007/s00198-006-0253-4.
How to Cite
Al-Bustany, D. (2025). Prevalence and factors associated with osteoporosis in patients with type 2 diabetes mellitus . Zanco Journal of Medical Sciences (Zanco J Med Sci), 29(2), 270–278. https://doi.org/10.15218/zjms.2025.028

Send mail to Author

Send Cancel